Literature DB >> 20495186

Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11betaHSD1-deficient mice post-MI.

Sara J McSweeney1, Patrick W F Hadoke, Agnieszka M Kozak, Gary R Small, Hiba Khaled, Brian R Walker, Gillian A Gray.   

Abstract

AIMS: Mice unable to locally regenerate corticosterone due to deficiency of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) have enhanced angiogenesis during acute myocardial infarct healing. The present study investigates the hypotheses that in these mice (i) inflammation and angiogenic signalling are promoted and (ii) longer-term remodelling and function are improved. METHODS AND
RESULTS: Myocardial infarction (MI) was induced by coronary artery ligation in 11βHSD1(-/-) and wild-type (C57BL/6) mice. Studies were terminated 2, 4, 7, and 28 days post-surgery. Increased vessel density (CD31 immunoreactivity) on the infarct border was confirmed 7 days after MI in 11βHSD1(-/-) hearts (P < 0.05) and was accompanied by improved ejection fraction (ultrasound) compared with C57BL/6. During wound healing, recruitment of neutrophils (at 2 days after MI) and macrophages (from 4 days after MI) and expression of monocyte-chemoattractant protein-1 was increased in 11βHSD1(-/-) compared with C57BL/6 hearts (P < 0.05). Recruitment of alternatively activated YM1-positive macrophages was particularly enhanced in the period preceding increased vessel density and was accompanied by increased expression of pro-angiogenic IL-8. By 28 days post-MI, when the infarct scar had matured, higher vessel density was maintained in 11βHSD1(-/-) hearts and vessels were smooth-muscle coated. Infarct scars were thicker (P < 0.001) in 11βHSD1(-/-) compared with C57BL/6 hearts and ejection fraction was higher (P < 0.05).
CONCLUSION: Increased vessel density in healing infarcts of mice deficient in 11(-/-)HSD1 follows recruitment of pro-reparative macrophages and increased pro-angiogenic signalling. Mature infarcts show less thinning and cardiac function is improved relative to wild-type mice, suggesting that 11βHSD1 may be a novel therapeutic target after MI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495186      PMCID: PMC3999375          DOI: 10.1093/cvr/cvq149

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  55 in total

Review 1.  Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.

Authors:  J R Seckl; B R Walker
Journal:  Endocrinology       Date:  2001-04       Impact factor: 4.736

Review 2.  Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction.

Authors:  Gabriel P Lasala; José J Minguell
Journal:  Heart Lung Circ       Date:  2008-12-09       Impact factor: 2.975

3.  11 Beta-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages.

Authors:  R Thieringer; C B Le Grand; L Carbin; T Q Cai; B Wong; S D Wright; A Hermanowski-Vosatka
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

4.  Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart.

Authors:  T Kakio; A Matsumori; K Ono; H Ito; K Matsushima; S Sasayama
Journal:  Lab Invest       Date:  2000-07       Impact factor: 5.662

Review 5.  The inflammatory response in myocardial infarction.

Authors:  Nikolaos G Frangogiannis; C Wayne Smith; Mark L Entman
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

6.  Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase.

Authors:  P W Hadoke; C Christy; Y V Kotelevtsev; B C Williams; C J Kenyon; J R Seckl; J J Mullins; B R Walker
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

7.  11beta-Hydroxysteroid dehydrogenase in the heart of normotensive and hypertensive rats.

Authors:  Karla Mazancová; Martin Kopecký; Ivan Miksík; Jirí Pácha
Journal:  J Steroid Biochem Mol Biol       Date:  2005-03-23       Impact factor: 4.292

8.  Enhanced myocardial angiogenesis by gene transfer with transplanted cells.

Authors:  T M Yau; K Fung; R D Weisel; T Fujii; D A Mickle; R K Li
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

9.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

10.  Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.

Authors:  H J Harris; Y Kotelevtsev; J J Mullins; J R Seckl; M C Holmes
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

View more
  33 in total

1.  Absence of mannose-binding lectin prevents hyperglycemic cardiovascular complications.

Authors:  Vasile I Pavlov; Laura R La Bonte; William M Baldwin; Maciej M Markiewski; John D Lambris; Gregory L Stahl
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  Selective inhibition and augmentation of alternative macrophage activation by progesterone.

Authors:  Fiona M Menzies; Fiona L Henriquez; James Alexander; Craig W Roberts
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

3.  Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.

Authors:  Ana Tiganescu; Melanie Hupe; Yoshikazu Uchida; Theadora Mauro; Peter M Elias; Walter M Holleran
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

4.  Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction.

Authors:  Yunzhe Wang; Cong-Lin Liu; Wenqian Fang; Xian Zhang; Chongzhe Yang; Jie Li; Jing Liu; Galina K Sukhova; Michael F Gurish; Peter Libby; Guo-Ping Shi; Jinying Zhang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-01-11       Impact factor: 5.187

Review 5.  The role of tissue engineering and biomaterials in cardiac regenerative medicine.

Authors:  Yimu Zhao; Nicole T Feric; Nimalan Thavandiran; Sara S Nunes; Milica Radisic
Journal:  Can J Cardiol       Date:  2014-09-04       Impact factor: 5.223

6.  N-acetyl-seryl-aspartyl-lysyl-proline treatment protects heart against excessive myocardial injury and heart failure in mice.

Authors:  Hongmei Peng; Jiang Xu; Xiao-Ping Yang; Kamal M Kassem; Imane A Rhaleb; Ed Peterson; Nour-Eddine Rhaleb
Journal:  Can J Physiol Pharmacol       Date:  2019-04-18       Impact factor: 2.273

Review 7.  Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?

Authors:  Andreas Stomby; Ruth Andrew; Brian R Walker; Tommy Olsson
Journal:  Diabetologia       Date:  2014-04-08       Impact factor: 10.122

Review 8.  11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease.

Authors:  Anna Anderson; Brian R Walker
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 9.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

10.  Intermittent hypoxia changes the interaction of the kinin-VEGF system and impairs myocardial angiogenesis in the hypertrophic heart.

Authors:  Bruna Visniauskas; Juliana C Perry; Guiomar N Gomes; Amanda Nogueira-Pedro; Edgar J Paredes-Gamero; Sergio Tufik; Jair R Chagas
Journal:  Physiol Rep       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.